Differentially expressed proteins of MCF-7 human breast cancer cells affected by Zilongjin, a complementary Chinese herbal medicine.

2.50
Hdl Handle:
http://hdl.handle.net/10547/228919
Title:
Differentially expressed proteins of MCF-7 human breast cancer cells affected by Zilongjin, a complementary Chinese herbal medicine.
Authors:
Tian, Zhi-Hua; Li, Zheng-Fu; Zhou, Shao-Bo ( 0000-0001-5214-2973 ) ; Liang, Yun-Yan; He, Da-Cheng; Wang, Dai-Shu
Abstract:
Zilongjin, a complementary Chinese herbal medicine, has been used to alleviate the adverse effects of chemotherapeutic drugs in cancer therapy. However, the mechanisms of anti-cancer activity of Zilongjin are still largely unkonwn.
Affiliation:
Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, PR China.
Citation:
Differentially expressed proteins of MCF-7 human breast cancer cells affected by Zilongjin, a complementary Chinese herbal medicine. 2010, 4 (5):550-559 Proteomics Clin Appl
Publisher:
Wiley-VCH Verlag
Journal:
Proteomics. Clinical applications
Issue Date:
May-2010
URI:
http://hdl.handle.net/10547/228919
DOI:
10.1002/prca.200900092
PubMed ID:
21137072
Additional Links:
http://onlinelibrary.wiley.com/doi/10.1002/prca.200900092/abstract
Type:
Article
Language:
en
ISSN:
1862-8354
Appears in Collections:
Cell and Cryobiology Research Group

Full metadata record

DC FieldValue Language
dc.contributor.authorTian, Zhi-Huaen_GB
dc.contributor.authorLi, Zheng-Fuen_GB
dc.contributor.authorZhou, Shao-Boen_GB
dc.contributor.authorLiang, Yun-Yanen_GB
dc.contributor.authorHe, Da-Chengen_GB
dc.contributor.authorWang, Dai-Shuen_GB
dc.date.accessioned2012-06-14T11:10:17Z-
dc.date.available2012-06-14T11:10:17Z-
dc.date.issued2010-05-
dc.identifier.citationDifferentially expressed proteins of MCF-7 human breast cancer cells affected by Zilongjin, a complementary Chinese herbal medicine. 2010, 4 (5):550-559 Proteomics Clin Applen_GB
dc.identifier.issn1862-8354-
dc.identifier.pmid21137072-
dc.identifier.doi10.1002/prca.200900092-
dc.identifier.urihttp://hdl.handle.net/10547/228919-
dc.description.abstractZilongjin, a complementary Chinese herbal medicine, has been used to alleviate the adverse effects of chemotherapeutic drugs in cancer therapy. However, the mechanisms of anti-cancer activity of Zilongjin are still largely unkonwn.en_GB
dc.language.isoenen
dc.publisherWiley-VCH Verlagen_GB
dc.relation.urlhttp://onlinelibrary.wiley.com/doi/10.1002/prca.200900092/abstracten_GB
dc.rightsArchived with thanks to Proteomics. Clinical applicationsen_GB
dc.subject.meshBreast Neoplasms-
dc.subject.meshCell Line, Tumor-
dc.subject.meshDown-Regulation-
dc.subject.meshDrugs, Chinese Herbal-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshNeoplasm Proteins-
dc.subject.meshProteomics-
dc.subject.meshUp-Regulation-
dc.titleDifferentially expressed proteins of MCF-7 human breast cancer cells affected by Zilongjin, a complementary Chinese herbal medicine.en
dc.typeArticleen
dc.contributor.departmentKey Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, PR China.en_GB
dc.identifier.journalProteomics. Clinical applicationsen_GB
All Items in UOBREP are protected by copyright, with all rights reserved, unless otherwise indicated.